THACI, D.; MENTER, A.; WU, J. J.; ARIKAN, D.; KUPPER, H.; BERESWILL, M.; VALDECANTOS, W. C. Long-Term Safety and Effectiveness of Adalimumab for Moderat-to-Severe Psoriasis: Results from the Eight-Year Interim Analysis of the ESPIRIT Registry. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 1, n. 3.1, p. s22, 2017. DOI: 10.25251/skin.1.supp.21. Disponível em: https://skin.dermsquared.com/skin/article/view/79. Acesso em: 9 jan. 2025.